A Study of Prevalence of EGFR Mutations in Participants With NSCLC

An Epidemiology Study of the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients Diagnosed With Non-squamous Non-small Cell Lung Cancer (NSCLC)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02695849

Enrollment

Registered

2016-03-01

Start date

2012-03-31

Completion date

2015-05-31

Last updated

2016-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

Keywords

Non-small cell lung cancer (NSCLC)

Brief summary

This is a non-interventional, local, multicenter, cross-sectional study to determine the prevalence of epidermal growth factor receptor (EGFR) mutations in participants diagnosed with non-squamous non-small cell lung cancer (NSCLC).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Informed consent form signature * Jordanian male and female participants greater than or equal to (\>=) 18 years of age * Histologically confirmed NSCLC * Not participating in a study that involves an investigational agent within 30 days prior to enrollment

Exclusion criteria

* Other primary malignancy * Fine needle aspiration samples

Design outcomes

Primary

Measure	Time frame
Percentage of Participants with EGFR mutations	Day 1

Secondary

Measure	Time frame
Percentage of Participants with types of EGFR mutations	Day 1

Countries

Jordan

Outcome results